Inventor · disambiguated record
Stewart Craig
Also filed as: CRAIG STEWART
10 granted patents·8 pending applications·3,518 citations·filing 1989–2021
93Inventor score
Files withXCYTE THERAPIES INC8ULTRAGENYX PHARMACEUTICAL INC4BRITISH BIOTECH PHARM2INVITROGEN CORP2BRITISH BIO TECHNOLOGY1
Top patents by PatentIndex Score
18 records- 0197US6905874B2Simultaneous stimulation and concentration of cellsXCYTE THERAPIES INC·Filed 2001·Granted Jun 14, 2005·950 cites·43 claims
- 0297US6867041B2Simultaneous stimulation and concentration of cellsXCYTE THERAPIES INC·Filed 2002·Granted Mar 15, 2005·935 cites·21 claims
- 0397US6797514B2Simultaneous stimulation and concentration of cellsXCYTE THERAPIES INC·Filed 2001·Granted Sep 28, 2004·985 cites·14 claims
- 0496US7572631B2Activation and expansion of T cellsINVITROGEN CORP·Filed 2005·Granted Aug 11, 2009·217 cites·7 claims
- 0591US6387367B1Human mesenchymal stem cellsOSIRIS THERAPEUTICS INC·Filed 1999·Granted May 14, 2002·328 cites·22 claims
- 0687US6057123AStem cell inhibiting proteinsBRITISH BIOTECH PHARM·Filed 1992·Granted May 2, 2000·66 cites·23 claims
- 0779US7541184B2Activation and expansion of cellsINVITROGEN CORP·Filed 2004·Granted Jun 2, 2009·10 cites·2 claims
- 0873US5856301AStem cell inhibiting proteinsBRITISH BIOTECH PHARM·Filed 1995·Granted Jan 5, 1999·21 cites·17 claims
- 0965US12472268B2Gene therapy for treating propionic acidemiaULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Granted Nov 18, 2025·0 cites·28 claims
- 1062US2005153447A1Activation and expansion of cellsXCYTE THERAPIES INC·Filed 2004·Application pending·0 cites
- 1162US2005214942A1Activation and expansion of cellsXCYTE THERAPIES INC·Filed 2004·Application pending·0 cites
- 1256US2003119185A1Activation and expansion of cellsXCYTE THERAPIES INC·Filed 2002·Application pending·0 cites
- 1355US2023235353A1Compositions and methods for reducing reverse packaging of cap and rep sequences in recombinant aavULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 1454US2023129893A1Gene therapy for treating propionic acidemiaULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 1550US5232847AHuman tissue plasminogen activator analogue having substitutions at amino acid positions 66, 67 and 68BRITISH BIO TECHNOLOGY·Filed 1989·Granted Aug 3, 1993·6 cites·1 claims
- 1649US2003082806A1Maturation of antigen-presenting cells using activated T cellsXCYTE THERAPIES INC·Filed 2002·Application pending·0 cites
- 1744US2023054144A1Gene therapy for treating cdkl5 deficiency disorderULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 1842US2003235908A1Activation and expansion of cellsXCYTE THERAPIES INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stewart Craig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →